Genmab A/S Sponsored ADR GMAB

35.32 0.49 1.41% as of 25 Sep
Market cap
$20.8B
P/E
27.8×
Growth Flags show if company had growth for consecutive years

An Income Statement, also known as a Profit and Loss Statement, summarizes a company's revenues, expenses, and profits over a specific period. It highlights how revenue is transformed into net income, showcasing operational efficiency. Key components include total revenue, cost of goods sold (COGS), gross profit, operating expenses, and net profit. Businesses use the Income Statement to assess financial performance, make strategic decisions, and ensure profitability. Investors and stakeholders analyze it to gauge the company’s financial health and future growth potential.

Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
Revenue
257.59 380.84 479.18 804.36 1,549.01 1,349.49 2,066.65 2,392.03 3,121.00 3,720.00
Revenue Growth
(32.36%) 47.85% 25.82% 67.86% 92.58% (12.88%) 53.14% 15.74% 30.48% 19.19%
Cost of Revenue
— — — — — — — 32.82 143.00 238.00
Gross Profit
— — 479.18 804.36 1,549.01 1,349.49 2,066.65 2,359.21 2,978.00 3,482.00
R&D Expenses
87.94 129.63 226.70 357.66 480.59 665.20 787.58 1,107.88 1,414.00 1,606.00
SG&A Expenses
14.47 23.67 33.85 51.27 101.27 204.13 378.92 478.72 549.00 626.00
Operating Income
— — 218.64 395.44 967.15 480.16 900.15 772.61 972.00 1,065.00
Interest Expense (Operating)
0.00 0.48 — — — — — — — —
Non-operating Income/Expense
8.94 (45.25) 36.70 33.13 (62.66) 153.53 96.00 45.88 354.00 139.00
Non-operating Interest Expenses
4.68 6.60 1.79 1.05 238.69 111.69 96.29 136.78 291.00 269.00
EBT
160.28 171.34 255.34 428.56 904.49 633.70 996.16 818.49 1,326.00 1,204.00
Income Tax Provision
(8.09) (6.44) 22.15 103.88 175.57 155.12 214.24 186.58 193.00 241.00
Income after Tax
— — 233.19 324.68 728.93 478.57 781.92 631.91 1,133.00 963.00
Net Income Common
168.37 177.78 233.19 324.68 728.93 478.57 781.92 631.91 1,133.00 963.00
EPS (Basic)
2.81 2.92 0.38 0.52 1.12 0.73 1.16 0.97 1.77 1.55
EPS (Diluted)
2.73 2.86 0.38 0.51 1.12 0.72 1.15 0.96 1.76 1.54
Shares (Basic, Weighted)
603.87 619.02 612.63 629.63 651.79 653.96 653.87 653.10 641.87 621.51
Shares (Diluted, Weighted)
624.00 629.17 620.37 636.37 658.86 660.46 660.10 659.15 646.56 626.92
Gross Margin
0.00% 0.00% 100.00% 100.00% 100.00% 100.00% 100.00% 98.63% 95.42% 93.60%
EBIT Margin
115.97% 115.52% 45.63% 49.16% 62.44% 35.58% 43.56% 32.30% 31.14% 28.63%
EBT margin
62.22% 44.99% 53.29% 53.28% 58.39% 46.96% 48.20% 34.22% 42.49% 32.37%
Net Profit Margin
65.36% 46.68% 48.66% 40.37% 47.06% 35.46% 37.83% 26.42% 36.30% 25.89%
Free Cash Flow Margin
18.06% 67.19% 17.77% 22.64% 60.59% 23.30% 24.63% 42.52% 33.80% (163.55%)
EBITDA
155.18 227.70 232.51 416.27 1,006.83 519.62 951.41 815.44 1,032.00 1,136.00
EBIT
298.72 439.94 218.64 395.44 967.15 480.16 900.15 772.61 972.00 1,065.00
Income from Continuous Operations
— — 233.19 324.68 728.93 478.57 781.92 631.91 1,133.00 963.00
Consolidated Net Income/Loss
168.37 177.78 233.19 324.68 728.93 478.57 781.92 631.91 1,133.00 963.00
EPS (Basic, from Continuous Ops)
— — 0.38 0.52 1.12 0.73 1.20 0.97 1.77 1.55
EPS (Basic, Consolidated)
— — 0.38 0.52 1.12 0.73 1.20 0.97 1.77 1.55
EPS (Diluted, from Cont. Ops)
— — 0.38 0.51 1.11 0.72 1.18 0.96 1.75 1.54
Shares (Diluted, Average)
— — 62.04 636.37 651.78 660.46 653.88 659.15 646.33 626.16
EPS (Diluted, Consolidated)
— — 0.38 0.51 1.11 0.72 1.18 0.96 1.75 1.54
EBITDA Margin
60.24% 59.79% 48.52% 51.75% 65.00% 38.51% 46.04% 34.09% 33.07% 30.54%
Operating Cash Flow Margin
18.06% 67.19% 33.55% 24.71% 63.62% 26.27% 26.80% 44.80% 36.08% 31.88%

Fold the line items

In millions of $ except per-share values · columns are period end dates